more than 100 000 patients, the modern treatment of POP was associated with 30% of patients suffering from nausea, 20% from vomiting, and 24% from excessive sedation. 2 Recently, experts proposed a new, organizational approach, based on our understanding of the pathophysiology of acute pain, the pharmacology of analgesics and clinical requirements, as an immediate solution for improving the management of POP. 7 This approach applies three principles in routine clinical practice, to achieve an effective POP management: (i) multimodal therapies 8 reflected in; (ii) evidencebased procedure-specific protocols 9 ; (iii) adjusted to the patients' individual analgesic requirements. 10 In Germany, several groups of experts in the field of POP, supported by quality assurance methodology, used these three principles to initiate quality management systems (QMSs) aimed at improving POP treatment. 11 One of these QMS, entitled 'Treatment of postoperative and posttraumatic pain', guided and certified by the German quality and safety monitoring agency, TÜ V Rheinland, 12 was introduced in 2008
at the University Hospital of Greifswald (Germany). This teaching hospital has 880 beds, 406 of which belong to 11 surgical departments. The QMS has been introduced in all surgical departments. The aim of our investigation was to evaluate the clinical effectiveness of the QMS, introduced at the university hospital and to study the results of its implementation on patients' satisfaction with the treatment of POP and its influence on quality of life.
Methods

Design of the investigation and selection criteria
This prospective anonymous pre/post questionnaire investigation was conducted at the university hospital. After approval from the local ethics committee, patients from 4 (175 beds) of the 11 surgical departments such as visceral surgery, gynaecology, orthopaedics, and traumatology were consecutively enrolled, in accordance with selection criteria in two prospective surveys. Patients, who undergo elective surgery with anticipated intensity of POP of ≥3/10 on an 11-point NRS (a priori defined procedure-specific POP intensity, depending on the size and localization of surgical lesion), 13 were asked to participate in the survey. The patients had to be able to fill out the study questionnaire on the first postoperative day and on the day of discharge and gave their informed signed consent to participate in the study. Patients, who were younger than 18 yr old, with chronic pain and those with insufficient knowledge of the German language or with cognitive limitations were not included. The patients were informed that they would be participating in a routine quality assurance survey of the hospital, thus the patients remained unaware 'blinded' of the purpose of the investigation. Survey 1 was performed at baseline from January to June 2008; Survey 2 was performed after the implementation of QMS from September 2009 to March 2010 (Fig. 1) .
Quality management system
A QMS for the treatment of POP, including successful methodologies described elsewhere, 14 -16 was introduced in all 11 surgical departments of the hospital. QMS included:
(i) structured patient information about POP treatment (including patient flyers with detailed descriptions of pain measurement methods and POP treatment modalities); (ii) procedure-specific, multimodal analgesic protocols, modified to meet the patients' individual requirements, based on guidelines for treatment of POP compiled by an international team of experts 9 and by experts of the German Society of Anaesthesiology and Intensive Care (DGAI) 17 (hospital-internal pathways are given in Figure 2 and Supplementary A and B); (iii) standardized pain measurement (at least once every 8 h), its documentation, and therapeutic consequences of pain level .3 as measured on a numerical rating scale 11 (0¼no pain; 10¼maximal pain imaginable);
Pilot study (n=30) 
General analgesic regimens
Basic analgesia was provided by the non-opioid analgesics acetaminophen, ibuprofen, and metamizole (Fig. 2) . In cases of expected moderate-to-severe pain, opioids were added, including oral tramadol or parenteral piritramide (opioid receptor agonist with 0.7 analgesic potency of morphine), applied via patient-controlled analgesia pumps 
Survey methodology
A pilot pre-test study was performed on 30 patients to obtain the data for the calculation of the sample size for the present study and to test the POP questionnaire (POP-Q). POP-Q was developed on the basis of a previously validated Brief Pain Inventory 19 and included:
Five items to report on the 1st postoperative day (POP-Qs); Nine items to report on the day of discharge (POP-Qd).
The five items of POP-Qs were: the intensity of (i) maximal pain; (ii) minimal pain after surgery; (iii) pain while at rest and while in movement at that moment; (iv) presence of tiredness, nausea, and vomiting; (v) satisfaction with pain therapy. Pain on movement was registered as the pain intensity during physiotherapeutic mobilization in patients after musculoskeletal surgery; after thoracic and abdominal surgery pain on coughing was the equivalent. The nine items of POP-Qd included the five POP-Qs items supplemented by: (i) presence of POP at all; (ii) pain intensity while at rest and while in movement immediately after surgery; (iii) whether pain disturbed the following aspects: sleep, mood, mobility, communication with others, and enjoyment of life; (iv) whether the patient had received analgesics for more than 6 months before the surgery.
All items concerning pain intensity were measured using a visual rating scale (VRS-11) from 0¼no pain to 10¼maximal Quality management system improves postoperative pain treatment BJA 89 pain imaginable. Satisfaction with the POP treatment was measured using a VRS-5 from 1¼excellent to 5¼bad, which, to facilitate the rating, resembles the scale of grades in German schools. On the day of surgery, consecutive patients were selected according to the eligibility criteria, using the data from intranet software with the surgery plan. On the first postoperative day, these patients received and filled out the POP-Qs. The POP-Qd was left for patients until the day of discharge, whereas the nurses of the department were asked to collect the completed POP-Qd.
Measurement of results and statistics
The intensity of pain taken on VRS-11, side-effects of analgesia, life quality items and patients' satisfaction with their POP treatment were registered as the measurement of results. Moreover, to compare the severity of surgical procedures between the surveys, each patient received the value of a priori defined POP intensity, using the previously described procedure-specific POP intensity scale. 13 An experienced consultant surgeon (J.L.) blindly scaled all surgeries using that a priori POP intensity scale.
To calculate the sample size, we used the data from a pilot pre-test study, assuming a probability of 0.05 and power of 80%. To detect a reduction in POP intensity of at least 30% from baseline, we calculated a sample size of at least 240 patients for each period of measurement pre/post (60 patients from each department). Anticipating a poor rate of returned questionnaires in the survey investigations, we planned to distribute 300 PPQ for each pre/post survey.
The collected data from Survey 1 was compared with that of Survey 2, using the SPSS 19.0 for Mac software and both presented as mean values with standard deviation or median with interquartile range, to give better characteristics of data distribution. Normally, distributed data were analysed using Student's t-test, skewed data were compared using the Mann-Whitney test. Binomially distributed data were analysed using the x 2 test and presented as frequency distribution with absolute numbers and relative distribution in per cent.
Results
Baseline data
The POP questionnaire was returned by 269 (91%) of the patients from Survey 1 (before QMS implementation) and by 251 (85%) from Survey 2 (after QMS implementation).
The collective of the Survey 1 patients was comparable with that of the Survey 2, in terms of patient characteristics, ASA health status, and prevalence of analgesic use for more than 6 months before the surgery ( Table 1 ). The patients from both surveys received perioperative catheters for regional and EDA in a comparable number of cases. The anticipated a priori pain intensity scores 13 were also similar in patients from both surveys ( Table 1 ). The detailed number of surgical procedures is given in Table 2 .
Pain levels
Survey 2 patients reported less pain than their counterparts in Survey 1 in all categories and time-points of measurement (Table 3) . Maximal pain intensity after surgery reported by Survey 2 patients was lower than that reported by Survey 1: 4.6 (95% CI: 4.3 -4.9) vs 6.0 (95% CI: 5.7-6.3); P,0.0001, as well as Survey 2's pain while in movement on the first postoperative day being reported as less than Survey 1's: 3.6 (95% CI: 3.3 -3.8) vs 4.9 (95% CI: 4.6-5.2), P,0.0001. Before the implementation of the QMS, the patients were discharged to go home with a pain intensity (in movement) of 2.7 (95% CI: 2.5-2.9), after QMS implementation the patients reported 1.6 (95% CI: 1.5-1.8); P,0.0001, before their being discharged. The analysis of the prevalence for weak, moderate, and severe pain intensity on movement, taken on the first postoperative day, demonstrated that 43% of the Survey 1 patients vs 13% of the patients from Survey 2 had reported severe pain (defined as higher than 6 on the 10-point scale of VRS-11; P,0.0001). Figure 3 gives the prevalence of severe pain, split to levels 6-7 (VRS-11) and 8-10 (extremely high pain). Extremely high pain was reported by 19% of the Survey 1 patients vs 3% of Survey 2 patients (P,0.0001). Four per cent of the Survey 1 patients vs 9% of their Survey 2 counterparts had reported no pain at all after surgery (P¼0.02).
Analgesia-related side-effects
Analgesic side-effects, such as nausea, vomiting, and tiredness, decreased to nearly half after implementation of QMS. Thirty-eight per cent of the Survey 1 patients vs 26% reported nausea on the first postoperative day (P¼0.003), on the day of discharge, there were 40% of the Survey 1 patients, who reported nausea vs 17% in Survey 2 (P,0.0001; Fig. 4 ). Vomiting was reported by 24% of the Survey 1 patients and by 18% in Survey 2 on the first postoperative day (P¼0.1); on the day of discharge, 25% of the patients from Survey 1 and 11% from Survey 2 reported vomiting (P,0.0001). Eighty-one per cent of the Survey 1 patients and 51% from Survey 2 mentioned tiredness on the first postoperative day; on the day of discharge, 76% of the Survey 1 patients and 30% of the patients in Survey 2 reported this side-effect of opioid analgesia (P,0.0001).
Items of life quality and satisfaction with pain therapy
The implementation of QMS was associated with an improvement of measured items of life quality that usually are disturbed by pain in the postoperative period. On the day of discharge, 84% of the Survey 1 patients and 72% of the Survey 2 (P¼0.01) reported that POP disturbed general activity. Sixty-five per cent of the patients of Survey 1 vs 47% of Survey 2 (P,0.0001) complained that POP disturbed their sleep. POP disturbed the enjoyment of life in 55% of the Survey 1 patients vs 39% of the Survey 2 patients (P¼0.001). Satisfaction with the therapy of POP also improved in Survey 2 vs in Survey 1 (P,0.001; Table 4 ).
Discussion
The introduction of the QMS for treatment of POP, based on clinical implementation of evidence-based procedure-specific protocols of multimodal analgesia, adjusted to individual patients' requirements has led to an improvement of the POP treatment in surgical patients at the university hospital. The implementation of QMS was associated with lower POP levels and with a simultaneous reduction of analgesia-related side-effects, improved daily activity, sleep, and an overall satisfaction with the treatment of POP. The values of clinically relevant pain categories (maximal pain and pain on movement) were reduced by 25-30% from the baseline level (Survey 1) after implementation of QMS (Table 2 ). Baseline levels of pain intensity, measured at 5 -6 (median, VRS-11) for maximal pain and at 5 for pain while in movement, are in accordance with previous investigations of the same design, which also described the pain-reducing Amputation/resection of bone parts 1 3
Surgery of skin and skin appendages 1 3
Reconstruction of ligaments and muscles 15 5 Missed data 1 0
Total number 269 251 The improvement in the mean POP values in our investigation is due to a decrease in patients with severe (6 -7; median on VRS-11) and extremely high (8-10 on VRS-11) pain after QMS implementation (Fig. 3) . Such a 'shift' in patients from the prevalence groups with a high level of POP to lower pain level groups, acceptable as not disturbing the quality of life (,4 on VRS-11) was also demonstrated in previous investigations, studying the implementation of comparable QMS. 14 20 Since no new drugs were introduced to the analgesic regimen at the time of the QMS implementation, the observed improvement in pain reduction is likely to be due to the combined effect of a rapid and more differentiated delivery of analgesics (preventive administration according to expected a priori pain intensity, early administration according to evidence-based procedure-specific guidelines, titration according to individual analgesic requirements of patients, etc.) as well as a number of unspecific factors. These factors include preoperative information to patients about the POP treatment, enhanced attention to treatment of pain, and related side-effects of analgesics by medical staff and regular visits by the acute pain service. 24 The frequency of the use of regional analgesia for POP treatment was comparable in patients' collectives from both surveys. However, we observed the dramatic reduction in opioid-related side-effects such as nausea, vomiting (N&V), and tiredness subsequent to the implementation of QMS (Fig. 4) . This nearly 50% reduction in the incidence of N&V can be explained by an initially high level (40% for nausea and 25% for vomiting) of these opioid-related sideeffects at baseline (Survey 1), on the one hand, and by the implementation of evidence-based guidelines for PONV prevention and treatment, 18 as an element of the QMS, on the other hand. The former was probably due to the pre-selection of the patients for this investigation who had received balanced general anaesthesia with volatile anaesthetic and opioid analgesics and who had required i.v. opioid analgesics for the POP treatment with the expected a priori pain level of .5 on NRS-11. Both of these treatments may have produced a high incidence of PONV, as reported by the patients during Survey 1, both on the first postoperative day and on the day of their discharge, but not by Survey 2 patients (Table 3) . During Survey 2, the incidence of both N&V decreased during the postoperative period, suggesting the effectiveness of QMS. Variations in tiredness showed a similar tendency: (i) a high level on both days of investigation at baseline (Survey 1); (ii) a decrease in Survey 2 in comparison with Survey 1 after QMS implementation; and (iii) a significant decrease during Survey 2 between the first postoperative day and the day of discharge. Interestingly, none of the previous investigations, which also have statistically demonstrated a significant decrease in pain levels, showed a decrease in analgesic-related side-effects. 14 -16 20 -22 It is likely that the 25-30% decrease in the POP level and the reduction in analgesic-related side-effects led to an improvement in daily activity, sleep, and enjoyment of life. However, the psychological effects of increased attention by medical staff cannot be ruled out. The patients' satisfaction with pain therapy had also improved after the implementation of the QMS.
These improvements in POP management can be partly attributed to the Hawthorne effect, when the act of measuring induces changes itself. However, the size of the Hawthorne effect is much smaller, than the effects found in our study 25 and it usually disappears within 8 weeks since the introduction of 'something new'. 26 Moreover, in order to keep the Hawthorne effect (motivation of personnel, participating in QMS on POP treatment) working, the German quality and safety monitoring agency, TÜ V Rheinland, incorporated special monitoring/quality assurance measures, including external and internal audits (see section 'Quality management system', statement x). The inability to apply a multi-centred, parallel-group randomized design was the major limitation of this study. However, it would be complicated to apply this 'gold standard' of clinical research because of organizational and ethical reasons. In fact, we do not see the single-centred design as a drawback: on the contrary, our carefully conducted investigation at a single institution had succeeded in demonstrating clinical improvement after QMS implementation. However, the large-scale patient survey, performed in 37 US hospitals after implementation of the Postoperative Pain Management Quality Improvement Project, demonstrated an improvement in structures and processes, critical to improving pain management (such as documented use of pain rating scales, decreased use of i.m. opioids, and the increased use of non-pharmacological strategies), although there was no change in pain results. 16 Our investigation was focused on the effectiveness of QMS for POP treatment, suggested previously in numerous publications, 6 7 9 11 12 27
and was not aimed at showing the causal links of expected changes. Another limitation was the absence of cost analysis, which might have provided insight into the causal relationships of changes discovered during the study. The next steps may be: (i) cost-effectiveness analysis, including expenses of personnel and analgesics, to evaluate the economic aspects of QMS implementation; (ii) study the influence of QMS on 'hard' clinical outcomes-perioperative morbidity and mortality; and (iii) prevent the development of persistent postsurgical pain. 28 The implementation of QMS has led to a clinically significant improvement of POP treatment, accompanied by a simultaneous decrease in analgesia-related side-effects, which have led to an increased quality of life and the satisfaction of the patients.
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